Cargando…

Long-term survival for COPD patients receiving noninvasive ventilation for acute respiratory failure

Implementation of noninvasive ventilation (NIV) as an add-on treatment has been routinely used in a non-intensive care setting since 2004 for patients with chronic obstructive pulmonary disease (COPD) and acute hypercapnic respiratory failure at a university hospital in Denmark. Although randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Titlestad, Ingrid L, Lassen, Annmarie T, Vestbo, Jørgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640597/
https://www.ncbi.nlm.nih.gov/pubmed/23650445
http://dx.doi.org/10.2147/COPD.S42632
_version_ 1782267930015170560
author Titlestad, Ingrid L
Lassen, Annmarie T
Vestbo, Jørgen
author_facet Titlestad, Ingrid L
Lassen, Annmarie T
Vestbo, Jørgen
author_sort Titlestad, Ingrid L
collection PubMed
description Implementation of noninvasive ventilation (NIV) as an add-on treatment has been routinely used in a non-intensive care setting since 2004 for patients with chronic obstructive pulmonary disease (COPD) and acute hypercapnic respiratory failure at a university hospital in Denmark. Although randomized controlled trials show lowered mortality rates in highly selected patients with acute exacerbation and respiratory failure, there are only few reports on long-term survival after receiving NIV. We present long-term all-cause mortality data from patients receiving NIV for the first time. METHOD: Data from medical records were retrospectively retrieved from all patients receiving NIV for the first time after being admitted acutely to an acute medical ward and further transfer to a respiratory ward with respiratory failure and a diagnosis of COPD in the period January 1, 2005 to December 31, 2007; patients were followed until January 2012. Demographic data collected included age, sex, diagnoses at discharge, and, when present, FEV(1); a “not-to-intubate” order was also registered when listed. RESULTS: In total, 253 patients (143 female, 110 male) received NIV for the first time. The median age was 72 years (range 46–91 years). The 30-day mortality rate was 29.3%. The 5-year survival rate was 23.7%. Women showed a trend towards better survival than men (25.7% vs 19.2%, P = 0.25), and the trend was even more pronounced for patients with COPD. CONCLUSION: The mortality rate of patients receiving NIV is high, as expected in a real-life setting, but with a 5-year survival rate of 23.7% with a trend towards more female than male long-term survivors.
format Online
Article
Text
id pubmed-3640597
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-36405972013-05-06 Long-term survival for COPD patients receiving noninvasive ventilation for acute respiratory failure Titlestad, Ingrid L Lassen, Annmarie T Vestbo, Jørgen Int J Chron Obstruct Pulmon Dis Original Research Implementation of noninvasive ventilation (NIV) as an add-on treatment has been routinely used in a non-intensive care setting since 2004 for patients with chronic obstructive pulmonary disease (COPD) and acute hypercapnic respiratory failure at a university hospital in Denmark. Although randomized controlled trials show lowered mortality rates in highly selected patients with acute exacerbation and respiratory failure, there are only few reports on long-term survival after receiving NIV. We present long-term all-cause mortality data from patients receiving NIV for the first time. METHOD: Data from medical records were retrospectively retrieved from all patients receiving NIV for the first time after being admitted acutely to an acute medical ward and further transfer to a respiratory ward with respiratory failure and a diagnosis of COPD in the period January 1, 2005 to December 31, 2007; patients were followed until January 2012. Demographic data collected included age, sex, diagnoses at discharge, and, when present, FEV(1); a “not-to-intubate” order was also registered when listed. RESULTS: In total, 253 patients (143 female, 110 male) received NIV for the first time. The median age was 72 years (range 46–91 years). The 30-day mortality rate was 29.3%. The 5-year survival rate was 23.7%. Women showed a trend towards better survival than men (25.7% vs 19.2%, P = 0.25), and the trend was even more pronounced for patients with COPD. CONCLUSION: The mortality rate of patients receiving NIV is high, as expected in a real-life setting, but with a 5-year survival rate of 23.7% with a trend towards more female than male long-term survivors. Dove Medical Press 2013 2013-04-26 /pmc/articles/PMC3640597/ /pubmed/23650445 http://dx.doi.org/10.2147/COPD.S42632 Text en © 2013 Titlestad et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Titlestad, Ingrid L
Lassen, Annmarie T
Vestbo, Jørgen
Long-term survival for COPD patients receiving noninvasive ventilation for acute respiratory failure
title Long-term survival for COPD patients receiving noninvasive ventilation for acute respiratory failure
title_full Long-term survival for COPD patients receiving noninvasive ventilation for acute respiratory failure
title_fullStr Long-term survival for COPD patients receiving noninvasive ventilation for acute respiratory failure
title_full_unstemmed Long-term survival for COPD patients receiving noninvasive ventilation for acute respiratory failure
title_short Long-term survival for COPD patients receiving noninvasive ventilation for acute respiratory failure
title_sort long-term survival for copd patients receiving noninvasive ventilation for acute respiratory failure
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640597/
https://www.ncbi.nlm.nih.gov/pubmed/23650445
http://dx.doi.org/10.2147/COPD.S42632
work_keys_str_mv AT titlestadingridl longtermsurvivalforcopdpatientsreceivingnoninvasiveventilationforacuterespiratoryfailure
AT lassenannmariet longtermsurvivalforcopdpatientsreceivingnoninvasiveventilationforacuterespiratoryfailure
AT vestbojørgen longtermsurvivalforcopdpatientsreceivingnoninvasiveventilationforacuterespiratoryfailure